MDxHealth SA banner
M

MDxHealth SA
NASDAQ:MDXH

Watchlist Manager
MDxHealth SA
NASDAQ:MDXH
Watchlist
Price: 0.6602 USD -13.13% Market Closed
Market Cap: $33.9m

Wall St Price Targets

MDXH Price Targets Summary
MDxHealth SA

Wall Street analysts forecast MDXH stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDXH is 7.548 USD with a low forecast of 6.06 USD and a high forecast of 9.45 USD.

Lowest Forecast
Price Target
6.06 USD
818% Upside
Average Forecast
Price Target
7.548 USD
1 043% Upside
Highest Forecast
Price Target
9.45 USD
1 331% Upside
MDxHealth SA Competitors:
Price Targets
MASI
Masimo Corp
1% Upside
CDNA
CareDx Inc
15% Upside
VINP
Vinci Partners Investments Ltd
42% Upside
VRNS
Varonis Systems Inc
-1% Downside

Revenue
Forecast

27% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss
27% / Year
Past Growth
11% / Year
Estimated Growth
Estimates Accuracy
-7%
Average Miss

Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 4 years is 11%.

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-39%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is MDXH's stock price target?
Price Target
7.548 USD

According to Wall Street analysts, the average 1-year price target for MDXH is 7.548 USD with a low forecast of 6.06 USD and a high forecast of 9.45 USD.

What is the Revenue forecast for MDxHealth SA?
Projected CAGR
11%

Over the last 14 years, the compound annual growth rate for Revenue has been 27%. The projected CAGR for the next 4 years is 11%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett